These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses. Schlosser PM; Lilly PD; Conolly RB; Janszen DB; Kimbell JS Risk Anal; 2003 Jun; 23(3):473-87. PubMed ID: 12836840 [TBL] [Abstract][Full Text] [Related]
3. Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset. Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ Toxicol Sci; 2004 Nov; 82(1):279-96. PubMed ID: 15254341 [TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of 1,3-butadiene and its epoxy intermediates. Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF; Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413 [TBL] [Abstract][Full Text] [Related]
5. Do rats comply with EPA policy on cancer risk assessment for formaldehyde? Brown LP Regul Toxicol Pharmacol; 1989 Oct; 10(2):196-200. PubMed ID: 2813872 [TBL] [Abstract][Full Text] [Related]
7. Risk assessment of laboratory rats and mice chronically exposed to formaldehyde vapors. Brown KG Risk Anal; 1985 Sep; 5(3):171-80. PubMed ID: 3916550 [TBL] [Abstract][Full Text] [Related]
8. The bottom-up approach to bounding potential low-dose cancer risks from formaldehyde: An update. Starr TB; Swenberg JA Regul Toxicol Pharmacol; 2016 Jun; 77():167-74. PubMed ID: 26851508 [TBL] [Abstract][Full Text] [Related]
9. The importance of delivered dose in estimating low-dose cancer risk from inhalation exposure to formaldehyde. Starr TB; Buck RD Fundam Appl Toxicol; 1984 Oct; 4(5):740-53. PubMed ID: 6510605 [TBL] [Abstract][Full Text] [Related]
10. Inhaled formaldehyde: evaluation of sensory irritation in relation to carcinogenicity. Arts JH; Rennen MA; de Heer C Regul Toxicol Pharmacol; 2006 Mar; 44(2):144-60. PubMed ID: 16413643 [TBL] [Abstract][Full Text] [Related]
11. A brief review of formaldehyde carcinogenesis in relation to rat nasal pathology and human health risk assessment. Morgan KT Toxicol Pathol; 1997; 25(3):291-307. PubMed ID: 9210261 [TBL] [Abstract][Full Text] [Related]
12. Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat. Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ Toxicol Sci; 2003 Oct; 75(2):432-47. PubMed ID: 12857938 [TBL] [Abstract][Full Text] [Related]
13. Formaldehyde and chemosensory irritation in humans: a controlled human exposure study. Lang I; Bruckner T; Triebig G Regul Toxicol Pharmacol; 2008 Feb; 50(1):23-36. PubMed ID: 17942205 [TBL] [Abstract][Full Text] [Related]
14. Dose response for formaldehyde-induced cytotoxicity in the human respiratory tract. Conolly RB; Kimbell JS; Janszen DB; Miller FJ Regul Toxicol Pharmacol; 2002 Feb; 35(1):32-43. PubMed ID: 11846634 [TBL] [Abstract][Full Text] [Related]
15. A 26-week inhalation toxicity study with formaldehyde in the monkey, rat, and hamster. Rusch GM; Clary JJ; Rinehart WE; Bolte HF Toxicol Appl Pharmacol; 1983 May; 68(3):329-43. PubMed ID: 6857667 [TBL] [Abstract][Full Text] [Related]
16. Experimental toxicology of formaldehyde. Bolt HM J Cancer Res Clin Oncol; 1987; 113(4):305-9. PubMed ID: 3298280 [TBL] [Abstract][Full Text] [Related]
17. A recommended occupational exposure limit for formaldehyde based on irritation. Paustenbach D; Alarie Y; Kulle T; Schachter N; Smith R; Swenberg J; Witschi H; Horowitz SB J Toxicol Environ Health; 1997 Feb; 50(3):217-63. PubMed ID: 9055874 [TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Isobutyraldehyde (CAS No. 78-84-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 472():1-242. PubMed ID: 12579201 [TBL] [Abstract][Full Text] [Related]
19. The use of noncancer endpoints as a basis for establishing a reference concentration for formaldehyde. Bender J Regul Toxicol Pharmacol; 2002 Feb; 35(1):23-31. PubMed ID: 11846633 [TBL] [Abstract][Full Text] [Related]
20. Exposure to repeated low-level formaldehyde in rats increases basal corticosterone levels and enhances the corticosterone response to subsequent formaldehyde. Sorg BA; Bailie TM; Tschirgi ML; Li N; Wu WR Brain Res; 2001 Apr; 898(2):314-20. PubMed ID: 11306018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]